Sunday, Oct 3, 8 AM

6th Annual Kelsey Bradley Favrot Memorial 5K Run/Walk

Virtual
$15 off for youths & seniors. $5 off for groups/teams., $30.00-$35.00

The race is on! The 6th Annual Kelsey Bradley Favrot Memorial 5K Run/Walk is Sunday, Oct. 3, 2021. Participate via our Virtual Run/Walk option After a one-year hiatus due to the pandemic, the Kelsey Bradley Favrot Memorial 5K Run/Walk will take place on Sunday, Oct. 3 in New Orleans. All proceeds from the event will go toward expanding pediatric neuro-oncology care at LSU Neurosurgery New Orleans. Runners/Walkers of all ages can register to participate virtually, from any location, at any time prior to Oct. 3. Registrations are now open for the virtual race. All registrants receive a commemorative t-shirt and race bib. Visit the registration page for instructions for the virtual event. This marks the 6th year for the fundraising run/walk honoring the late Kelsey Favrot’s wish that neuro-oncology care in New Orleans be among the best in the country so patients would not have to travel out of town for treatment. As a result of these efforts, neuro-oncology care has expanded at LSU Health New Orleans, Department of Neurosurgery. Dr. Aaron Mammoser is now in his 5th year as the Kelsey Bradley Favrot Chair in Neuro-Oncology, treating patients and overseeing several clinical trials for brain tumor patients. Entry fees: $30 pre-registration; $35 race day; $15 discount for youths and seniors Save $5.00 on registration fees by creating a group or team. Online registration and donations: kelseysgoal.com. Sponsorships are available by calling Wendy Roark in the LSU Neurosurgery Department at (504) 568-2582. On January 8th, 2008, Kelsey Favrot was diagnosed with a malignant brain tumor known as Gliomatosis Cerebri. During the next 20 months, Kelsey underwent surgery, radiation and chemotherapy with courage, hope and grace. Unfortunately, she had to receive treatment out of town because none of the hospitals in New Orleans had a physician whose primary focus was neuro-oncology. The distance was a hardship for Kelsey, her family and friends, who would have preferred she remain in New Orleans for care so they could be at her side. Throughout her treatment, Kelsey expressed concern for those brain cancer patients unable to travel out of state, whether constrained by their illness or financial considerations. With characteristic determination, Kelsey began to explore ways to assist those who would face a brain cancer diagnosis in the future. Kelsey succumbed to brain cancer in August 2009.